Testing the ACME score for gallbladder attack
Part of Digestive system clinical trials.
This study tests a new scoring system (called ACME) to predict how well people with sudden gallbladder inflammation and gallstones will do. It helps doctors make better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have acute calculous cholecystitis (sudden gallbladder inflammation caused by a gallstone).
- You cannot have acute cholangitis (a bacterial infection of the bile duct).
- You cannot have chronic cholecystitis (long-term gallbladder inflammation).
- You cannot have any cancer (neoplasia).
- You cannot have acute pancreatitis (sudden pancreas inflammation).
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new type of quick MRI scan can reliably detect acute cholecystitis—sudden inflammation of the gallbladder. If it works well, doctors may be able to diagnose this condition faster and help patients get treatment sooner.
This study looks at gut bacteria (your microbiome) in people with gallstones to better understand what’s going on in the body. It includes adults having gallbladder removal surgery, and it may help researchers find better ways to predict or treat gallstone disease.
This study looks at how older adults (70+) with acute gallbladder inflammation respond to different treatments over one year. It aims to find the best approach for this age group.
This trial looks at whether it is safe to delay treatment for a gallbladder infection in patients who have already had a special stent placed to drain the gallbladder. Patients who are too sick for surgery will be randomly assigned to receive either antibiotics with monitoring or immediate gallbladder removal.
This study is testing a tool to predict survival after gallbladder removal for people with acute cholecystitis caused by gallstones. By joining, you help doctors better assess risk and improve care for future patients.
This trial compares two minimally invasive treatments for people with severe gallbladder inflammation caused by gallstones. It aims to see which approach better helps the immune system and reduces risks for those who are too sick for standard surgery.
Hear when a new Acute Cholecystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.